Coretronic v. Maxell — Patent Pleading Survives While Bad-Faith Claims Fall Short

Background

Projector makers Coretronic and Optoma asked a California federal court to declare that their products do not infringe Maxell’s U.S. Patent No. 8,075,142, which covers an image-display apparatus. The dispute followed years of correspondence over Maxell’s patent portfolio and a December 2025 submission by Maxell to Amazon’s Patent Evaluation Express program. Coretronic and Optoma alleged that Maxell used that program to challenge sales of Optoma-branded projectors even after receiving information that, in the plaintiffs’ view, showed noninfringement and invalidity.

The complaint asserted declaratory-judgment claims for noninfringement and invalidity, as well as patent misuse, Walker Process antitrust fraud, tortious interference, and Washington-law claims based on alleged bad-faith patent enforcement. Maxell moved to dismiss the entire case at the pleading stage.

The Court’s Holding

Judge Eumi K. Lee allowed the core noninfringement claim to proceed. The complaint identified the accused projector models and explained why particular claim limitations were allegedly absent, giving Maxell fair notice of the plaintiffs’ theory. The court rejected the argument that a declaratory-judgment plaintiff must provide the level of detail ordinarily developed later through Patent Local Rule infringement contentions.

The invalidity claim also survived in substantial part. For anticipation, the plaintiffs identified three specific projector lines—the Optoma HD72 and HD73 and Hitachi CP-A100 series—as alleged prior art that practiced every limitation. That was enough at the pleading stage without a claim-by-claim chart. Because a disclosure that anticipates a claim necessarily can support an obviousness theory, the court also allowed the Section 103 theory to proceed. The indefiniteness theory did not survive, however, because the complaint invoked means-plus-function law without identifying which patent limitations allegedly lacked corresponding structure.

The court dismissed the remaining theories with leave to amend. The patent-misuse allegations did not plausibly show that Maxell knew its patent was invalid or unenforceable or that its conduct improperly broadened the patent’s scope. The Walker Process claim did not identify a material misrepresentation or omission to the Patent Office with the required specificity. The tortious-interference and Washington statutory claims likewise lacked facts connecting Maxell’s conduct to a sufficiently concrete business expectancy or showing the elements of an unfair or deceptive practice.

Key Takeaways

• A declaratory-judgment plaintiff can survive dismissal by identifying accused products, disputed claim limitations, and a concrete noninfringement theory; full infringement contentions are not required in the complaint.
• An invalidity pleading may be adequate when it names a statutory theory and specific prior-art products, even without mapping every claim limitation at the outset.
• Means-plus-function indefiniteness requires more detail: the pleading should identify the particular limitation and the allegedly missing corresponding structure.
• Bad-faith patent-enforcement and Walker Process theories demand facts beyond a disagreement over infringement or validity, including particularized allegations of knowing misconduct.

Why It Matters

The order draws a practical line between the factual detail needed to begin a patent declaratory-judgment case and the much more exacting showing needed to turn aggressive patent enforcement into an antitrust or unfair-competition claim. Accused infringers may reach discovery on noninfringement and invalidity by identifying products, claim issues, and prior art with reasonable specificity. But allegations that the patent owner acted improperly require concrete facts showing knowledge, deception, and resulting competitive harm.

For companies using marketplace patent-review programs, the ruling also shows that platform complaints can create a real controversy suitable for federal adjudication. At the same time, invoking such a program does not by itself establish patent misuse or bad faith.